LDX lumos diagnostics holdings limited

Ann: Investor Briefing on new Hologic Agreements, page-120

  1. 2,039 Posts.
    lightbulb Created with Sketch. 307
    I think people should look into Proteomics (PIQ) as an example of diagnostics / US healthcare comparison here. PIQ's PromarkerD diabetes diagnostics test is available in the US exclusive through Sonic Healthcare (Market Cap $15B AUD).

    Their recent quarterly (announced today) showed $410,000 revenue to date and costs of $1.3M YTD for their operating activities. Now needing to raise $6M via placement.

    Comparing to Lumos diagnostics which last quarterly showed $1.338M in revenue YTD and $2.448M costs YTD.

    PIQ priced at .91c with 121M shares outstanding (Commsec)

    LDX .077c with 480M shares outstanding (Commsec)

    Do I think that for the partners in place, the revenue received and incoming, and pipeline available that LDX is substantially undervalued?

    Yes.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.5¢
Change
0.004(4.40%)
Mkt cap ! $70.36M
Open High Low Value Volume
9.4¢ 9.8¢ 9.1¢ $1.025M 10.78M

Buyers (Bids)

No. Vol. Price($)
1 100000 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 25928 1
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.